Camrelizumab Combined With AVD in the First-line Treatment for Patients With Advanced Classical Hodgkin's Lymphoma
Clinical trial NCT04067037 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04067037
- Sponsor
- Henan Cancer Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-26
- Primary completion
- 2026-01-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.